These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31757663)

  • 21. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
    Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-36 s in the colorectal cancer: is interleukin 36 good or bad for the development of colorectal cancer?
    Chen F; Qu M; Zhang F; Tan Z; Xia Q; Hambly BD; Bao S; Tao K
    BMC Cancer; 2020 Feb; 20(1):92. PubMed ID: 32013927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer.
    Qian F; Xiao J; Hu B; Sun N; Yin W; Zhu J
    Hum Pathol; 2017 Jun; 64():61-68. PubMed ID: 28412208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of Rab31 is associated with poor prognosis and promotes colorectal carcinoma proliferation via the mTOR/p70S6K/Cyclin D1 signalling pathway.
    Yang L; Tian X; Chen X; Lin X; Tang C; Gao Y; Chen S; Ge Z
    Life Sci; 2020 Sep; 257():118126. PubMed ID: 32707053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
    Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
    Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of CHKA contributes to tumor progression and metastasis and predicts poor prognosis in colorectal carcinoma.
    Hu L; Wang RY; Cai J; Feng D; Yang GZ; Xu QG; Zhai YX; Zhang Y; Zhou WP; Cai QP
    Oncotarget; 2016 Oct; 7(41):66660-66678. PubMed ID: 27556502
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
    Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG
    ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human CAP10-Like Protein 46 kDa Gene Promotes Malignancy in Colorectal Cancer.
    Fang H; Chu Q; Zhang J; Wang H; Yu X; Ge S; Song M; Wu L; Lang M; Chang N; Wang Y; Wang W
    OMICS; 2017 May; 21(5):266-274. PubMed ID: 28481732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced expression of EphA5 is associated with lymph node metastasis, advanced TNM stage, and poor prognosis in colorectal carcinoma.
    Gu S; Feng J; Jin Q; Wang W; Zhang S
    Histol Histopathol; 2017 May; 32(5):491-497. PubMed ID: 27651378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer.
    Li HX; Sun XY; Yang SM; Wang Q; Wang ZY
    Pathol Res Pract; 2018 May; 214(5):655-660. PubMed ID: 29673884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic Value Investigation and Bioinformatics Analysis of miR-31 in Patients with Lymph Node Metastasis of Colorectal Cancer.
    Zhang WW; Ming XL; Rong Y; Huang CQ; Weng H; Chen H; Bian JM; Wang FB
    Anal Cell Pathol (Amst); 2019; 2019():9740475. PubMed ID: 31934534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
    Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
    Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic role of aberrant mTOR activation in patients with stage II and III colorectal cancer.
    Zhang TT; Zhu YQ; Cai HQ; Zheng JW; Hao JJ; Chang C; Cai Y; Wang MR; Liang JW; Zhang Y
    Biomark Med; 2020 Aug; 14(12):1127-1137. PubMed ID: 32969244
    [No Abstract]   [Full Text] [Related]  

  • 34. Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
    Vellinga TT; Kranenburg O; Frenkel N; Ubink I; Marvin D; Govaert K; van Schelven S; Hagendoorn J; Borel Rinkes IH
    Ann Surg; 2017 Nov; 266(5):765-771. PubMed ID: 28742689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
    Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
    Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer.
    Wei JL; Fu ZX; Fang M; Guo JB; Zhao QN; Lu WD; Zhou QY
    Oncol Rep; 2015 Mar; 33(3):1349-57. PubMed ID: 25572852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.
    Zeng J; Tang ZH; Liu S; Guo SS
    World J Gastroenterol; 2017 Mar; 23(10):1780-1786. PubMed ID: 28348483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic role of tumor associated glycoprotein 72 (TAG-72) in stage II and III colorectal adenocarcinoma.
    Cho J; Kim KM; Kim HC; Lee WY; Kang WK; Park YS; Ha SY
    Pathol Res Pract; 2019 Jan; 215(1):171-176. PubMed ID: 30466765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.